#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alpha-1 antitrypsin deficiency Gastrooesophageal cancer Basal cell naevus syndrome Non-small cell lung cancer Arrhythmogenic right ventricular dysplasia Ventricular fibrillation Uveitis Sarcoidosis Still's disease Amyotrophic lateral sclerosis gene carrier Primary myelofibrosis Encephalitis autoimmune Autoinflammation with infantile enterocolitis Guillain-Barre syndrome Fibrodysplasia ossificans progressiva More trials…

    Learn about Rare Diseases

    Angiosarcoma – Life with Disease VEXAS syndrome – Treatment Lysosomal storage disorder – Trials in Disease Friedreich’s ataxia – Treatment Mantle cell lymphoma refractory – Life with Disease Myelodysplastic syndrome – Trials in Disease Hyperoxaluria – Trials in Disease Acquired haemophilia – Life with Disease VEXAS syndrome – Trials in Disease Hereditary neuropathic amyloidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azd8421 Interferon Beta-1B Lna043 Neridronate Sodium Metformin Isaralgagene Civaparvovec E.coli Polysaccharide Trimetazidine Dihydrochloride Charcoal, Activated Doxycycline Hyclate Rigosertib Sodium Aminohippuric Acid Piracetam Naltrexone Hydrochloride Df6002 Idarubicin Dicloxacillin Buclizine Hydrochloride Escitalopram Oxalate Zenocutuzumab More therapies…

    Learn about Your Condition

    Bone hypertrophy Hairy cell leukaemia recurrent Neoplasm malignant Necrotising myositis Cachexia Pancreatic carcinoma stage IV Pleural mesothelioma CADASIL Periarthritis MELAS syndrome Ovarian cancer stage IV Pemphigus Delirium Ectopic pregnancy Spinal osteoarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on the Effects of GLM101 for Patients with PMM2-CDG

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Metabolic disorder
    Investigated Drugs:
    • Alfa-D-Mannopyranosyl Phosphate Dipotassium
    Spain

  • Study on the Effectiveness and Safety of OTL-203 for Patients with Hurler Syndrome (MPS-IH) Compared to Standard Treatment with Stem Cell Transplantation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Mucopolysaccharidosis I
    Investigated Drugs:
    • Autologous Cd34+ Haematopoietic Stem And Progenitor Cells Genetically Modified With The Lentiviral Vector Idua Lv, Encoding For The Alpha-L-Iduronidase Cdna
    • Laronidase
    • Plerixafor
    Italy The Netherlands

  • Remote Study on Empagliflozin and Finerenone for Reducing Kidney Issues in Type 2 Diabetes Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Albuminuria
    • Diabetic nephropathy
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Empagliflozin
    • Finerenone
    The Netherlands

  • Study on Reducing Protein in Urine for Patients with Chronic Kidney Disease Using Finerenone and Semaglutide

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    • Semaglutide
    Denmark Italy The Netherlands Spain

  • Study on the Effectiveness and Safety of Finerenone and Empagliflozin in Adults with Chronic Kidney Disease and Type 2 Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic nephropathy
    Investigated Drugs:
    • Empagliflozin
    • Finerenone
    Belgium Denmark France Germany Italy The Netherlands +1

  • Study on the Effects of Pasireotide in Patients with Low Blood Sugar After Bariatric Surgery

    Not recruiting

    2 1
    Investigated Drugs:
    • Pasireotide Diaspartate
    • Placebo
    Belgium France Italy Spain
Previous Page
1 … 47 48 49 50 51 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!